AVASCULAR NECROSIS
Clinical trials for AVASCULAR NECROSIS explained in plain language.
Never miss a new study
Get alerted when new AVASCULAR NECROSIS trials appear
Sign up with your email to follow new studies for AVASCULAR NECROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shoulder implant under watch: will it last?
Disease control Recruiting nowThis study follows 200 adults who receive the Medacta Shoulder System to see how long the implant lasts and how well the shoulder functions afterward. Participants have conditions like arthritis, rotator cuff problems, fractures, or need a replacement of a previous shoulder impla…
Matched conditions: AVASCULAR NECROSIS
Sponsor: Medacta International SA • Aim: Disease control
Last updated May 26, 2026 04:47 UTC
-
New knee implant study aims to improve mobility for 760 patients
Disease control Recruiting nowThis study is testing a knee implant called Persona in 760 people who need knee replacement surgery due to arthritis or other knee problems. The goal is to see if the implant is safe, works well, and helps patients move better and feel less pain. Participants will be followed for…
Matched conditions: AVASCULAR NECROSIS
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated May 26, 2026 04:41 UTC
-
10-Year shoulder implant study aims to improve joint replacement outcomes
Disease control Recruiting nowThis study follows 300 adults who need shoulder replacement due to arthritis, bone death, or rotator cuff damage. Researchers will track pain, function, and safety of the Perform Humeral System for up to 10 years after surgery. The goal is to confirm the implant works well and is…
Matched conditions: AVASCULAR NECROSIS
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated May 26, 2026 04:41 UTC
-
Can a common bone drug ease pain in sickle cell disease?
Disease control Recruiting nowThis study is testing whether alendronate, a drug used for osteoporosis, can help treat bone damage (osteonecrosis) in adults with sickle cell disease. About 30 participants will take the drug for 6 months to see if it reduces pain and improves quality of life. The study also che…
Matched conditions: AVASCULAR NECROSIS
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 19, 2026 11:46 UTC